[go: up one dir, main page]

NO965516D0 - Sterolderivater anvendt til regulering av meiose - Google Patents

Sterolderivater anvendt til regulering av meiose

Info

Publication number
NO965516D0
NO965516D0 NO965516A NO965516A NO965516D0 NO 965516 D0 NO965516 D0 NO 965516D0 NO 965516 A NO965516 A NO 965516A NO 965516 A NO965516 A NO 965516A NO 965516 D0 NO965516 D0 NO 965516D0
Authority
NO
Norway
Prior art keywords
sterol derivatives
derivatives used
regulate meiosis
meiosis
regulate
Prior art date
Application number
NO965516A
Other languages
English (en)
Other versions
NO965516L (no
NO314534B1 (no
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO965516D0 publication Critical patent/NO965516D0/no
Publication of NO965516L publication Critical patent/NO965516L/no
Publication of NO314534B1 publication Critical patent/NO314534B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19965516A 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro NO314534B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number Publication Date
NO965516D0 true NO965516D0 (no) 1996-12-20
NO965516L NO965516L (no) 1997-02-21
NO314534B1 NO314534B1 (no) 2003-04-07

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965516A NO314534B1 (no) 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro

Country Status (26)

Country Link
US (1) US5716777A (no)
EP (1) EP0767798B1 (no)
JP (1) JP3987105B2 (no)
KR (1) KR100408369B1 (no)
CN (1) CN1068333C (no)
AT (1) ATE248852T1 (no)
AU (1) AU694240B2 (no)
BG (1) BG101067A (no)
BR (1) BR9508074A (no)
CA (1) CA2192941C (no)
CZ (1) CZ289407B6 (no)
DE (1) DE69531682T2 (no)
DK (1) DK0767798T3 (no)
ES (1) ES2204955T3 (no)
FI (1) FI117159B (no)
HU (1) HUT76343A (no)
IL (1) IL114294A (no)
IS (1) IS4404A (no)
MX (1) MX9700174A (no)
NO (1) NO314534B1 (no)
PL (1) PL186688B1 (no)
RU (1) RU2194510C2 (no)
SI (1) SI9520077A (no)
SK (1) SK165596A3 (no)
UA (1) UA51622C2 (no)
WO (1) WO1996000235A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2188006C2 (ru) * 1995-03-06 2002-08-27 Ново Нордиск А/С Стимуляция мейоза
EP0857173B1 (en) * 1995-06-23 2003-11-19 Novo Nordisk A/S Meiosis regulating compounds
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
ATE238339T1 (de) 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
AU726016B2 (en) * 1997-05-16 2000-10-26 Akzo Nobel N.V. 20-aralkyl-5alpha-pregnane derivatives
PL337188A1 (en) * 1997-06-04 2000-08-14 Akzo Nobel Nv Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
ATE220686T1 (de) * 1997-12-18 2002-08-15 Akzo Nobel Nv 17beta-aryl(arylmethyl)oxy(thio)alkyl- androstanderivative
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
JP2002516272A (ja) * 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト cAMPを増大させる化合物を単独でまたは減数分裂を刺激する少なくとも1つの化合物との組合せ物での不妊治療
WO1999067273A1 (en) * 1998-06-19 1999-12-29 Novo Nordisk A/S Meiosis regulating compounds
US6528501B1 (en) * 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
PL350557A1 (en) * 1999-02-10 2002-12-16 Schering Ag Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
ES2258445T3 (es) 1999-02-24 2006-09-01 Novo Nordisk A/S Metodo in vitro para la sincronizacion de la maduracion de ovocitos.
AU2794000A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
DE60000978T2 (de) * 1999-03-09 2003-07-17 Akzo Nobel N.V., Arnheim/Arnhem 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
EP1216059B1 (en) * 1999-09-16 2005-10-19 Novo Nordisk A/S Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
US20040224878A1 (en) * 2000-05-18 2004-11-11 Suna Cukurcam Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CZ289407B6 (cs) 2002-01-16
BR9508074A (pt) 1997-08-12
ATE248852T1 (de) 2003-09-15
JP3987105B2 (ja) 2007-10-03
PL186688B1 (pl) 2004-02-27
ES2204955T3 (es) 2004-05-01
WO1996000235A1 (en) 1996-01-04
CN1068333C (zh) 2001-07-11
HUT76343A (en) 1997-08-28
IL114294A0 (en) 1995-10-31
AU694240B2 (en) 1998-07-16
FI965144A0 (fi) 1996-12-20
EP0767798B1 (en) 2003-09-03
DK0767798T3 (da) 2003-12-22
CA2192941C (en) 2009-04-14
NO965516L (no) 1997-02-21
US5716777A (en) 1998-02-10
EP0767798A1 (en) 1997-04-16
KR100408369B1 (ko) 2004-04-28
RU2194510C2 (ru) 2002-12-20
JPH10502060A (ja) 1998-02-24
IS4404A (is) 1996-12-23
BG101067A (en) 1997-08-29
SK165596A3 (en) 1997-08-06
MX9700174A (es) 1997-04-30
SI9520077A (sl) 1998-06-30
CZ372596A3 (en) 1997-07-16
CA2192941A1 (en) 1996-01-04
PL317830A1 (en) 1997-04-28
HU9603584D0 (en) 1997-02-28
FI965144L (fi) 1997-02-20
DE69531682D1 (de) 2003-10-09
CN1151164A (zh) 1997-06-04
FI117159B (fi) 2006-07-14
IL114294A (en) 2002-09-12
NO314534B1 (no) 2003-04-07
AU2734395A (en) 1996-01-19
UA51622C2 (uk) 2002-12-16
DE69531682T2 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
NO965516L (no) Sterolderivater anvendt til regulering av meiose
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
IT1285770B1 (it) Composti corticoidei
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
FI972387A0 (fi) Iholle levitettäviä parasitisidikoostumuksia
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
SE9801494D0 (sv) Novel use
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE227122T1 (de) Stabilisierte tablettenformulierung
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO965165D0 (no) Anvendelse av 8,9-dehydroestron som en antioksydant